Epidermal growth factor receptor mutation type iii transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype

✍ Scribed by Lars Damstrup; Mikkel Wandahl Pedersen; Lone Bastholm; Folmer Elling; Hans Skovgaard Poulsen

• Book ID: 102861947
• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: French
• Weight: 513 KB
• Volume: 97
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.1572

✦ Synopsis

Abstract

In the present study we transfected the epidermal growth factor receptor (EGFR)‐negative small cell lung cancer cell line, GLC3, with the type III EGFR mutation (EGFRvIII). The EGFRvIII protein could be detected by Western blot analysis as a 145‐kDa protein, which by immunohistochemistry appeared to be localized at the cell surface. Ultrastructurally EGFRvIII was expressed mainly at the cell surface with clusters at cell–cell contacts. In the in vitro invasion assay, GLC3‐EGFRvIII cells had a ≈5‐fold increased invasion compared with uninduced GLC3‐EGFRvIII, GLC3‐Tet‐On and the parental cell line. GLC3‐Tet‐On appeared uniform in size with adherence junctions at cell–cell contacts. In uninduced GLC3‐EGFRvIII cells adherence junctions were also present but less distinct. In doxycycline‐pretreated GLC3‐EGFRvIII cells, adherence junctions were absent. We conclude that the expression of EGFRvIII results in a more malignant phenotype. This effect appears to involve the disruption of adherence junctions. © 2002 Wiley‐Liss, Inc.